FDA approves Gemtesa for overactive bladder in men with benign prostatic hyperplasia
Sumitomo Pharma's Gemtesa (vibegron) has been approved by the U.S. Food and Drug Administration for men with overactive ...
Francis Medical raises $80 million for device that treats prostate cancer
Francis Medical Inc., a Twin Cities med-tech manufacturer that's developing a way to treat prostrate and other cancers with water vapor, said Tuesday it raised $80 million in its latest equity funding ...
WebMD4y
New Relief for Stress Incontinence
Women who suffer from stress urinary incontinence (SUI) worry about coughing, sneezing, even laughing in public for fear of having an accident. For some the fear of embarrassment is so great that ...